OCTRIDE DEPOT 30MG ING

About

Octreotide Depot is a synthetic long-acting analogue of somatostatin, a naturally occurring hormone. It is primarily used in the management of acromegaly, a condition caused by excessive growth hormone production, and in the treatment of symptoms associated with functional neuroendocrine tumors, such as carcinoid syndrome and VIPomas. By mimicking somatostatin, octreotide inhibits the secretion of various hormones, including growth hormone, insulin, glucagon, and gastrointestinal peptides. This sustained inhibition helps to control symptoms like severe diarrhea and flushing in carcinoid syndrome, and to reduce tumor growth and hormone levels in acromegaly. The depot formulation allows for extended release, providing consistent therapeutic levels over several weeks, which improves patient convenience and adherence compared to daily injections. Its clinical efficacy is well-established in reducing tumor burden and improving quality of life for affected patients.

Uses

• Management of acromegaly.
• Control of symptoms associated with carcinoid syndrome.
• Treatment of VIPomas (vasoactive intestinal peptide-secreting tumors).
• Management of glucagonomas.

Directions For Use

Administered by deep intramuscular injection into the gluteal region by a healthcare professional.

Benefits

• Sustained control of hormone-related symptoms.
• Reduced tumor growth in neuroendocrine tumors.
• Improved quality of life for patients.
• Convenient long-acting formulation (monthly dosing).
• Effective suppression of growth hormone in acromegaly.
• Reduces severe diarrhea and flushing in carcinoid syndrome.

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Gallstones or biliary sludge
• Injection site reactions (pain, swelling)
• Hyperglycemia or hypoglycemia
• Bradycardia
• Thyroid dysfunction
• Vitamin B12 deficiency
• Steatorrhea
• Headache
• Dizziness

Safety Measures

• Alcohol - No specific direct interaction, but alcohol can exacerbate gastrointestinal symptoms in some patients.
• Pregnancy - Use only if clearly indicated and the potential benefits outweigh the risks to the fetus.
• Breastfeeding - Excreted in breast milk; caution is advised, and a decision to discontinue breastfeeding or the drug should be made.
• Liver - Dose adjustment may be necessary in patients with severe hepatic impairment due to altered metabolism.
• Kidney - Generally, no dose adjustment is required for patients with renal impairment.
• Lung - No specific contraindications related to lung conditions, but monitor for any unusual respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.